Cryptocurrency Analysis and News Portal
Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030. Pfizer Inc (NYSE: PFE) has closed a $43 billion deal to acquire biotechnology company Seagen Inc and its leading line of cancer drugs. The deal comes as revenue
Read More
VitaDAO was started in 2021 by Tyler Golato of decentralized biotech protocol Molecule to fund longevity research. According to the organization, it boasts a community of over 9,000 "enthusiasts, researchers and contributors," and deployed over $3.5 million to projects researching diseases of aging, cellular biology and repairing age-related damage to
Read More
Bitcoin (BTC) stemmed some of its losses as Wall Street opened on Nov. 26 after concern over a new COVID-19 variant spark a global market sell-off.BTC/USD 1-hour candle chart (Bitstamp). Source: TradingViewPfizer gains as coronavirus panic sets inData from Cointelegraph Markets Pro and TradingView showed BTC/USD ending its downturn at just
Read More
The potential efficacy in the approved Pfizer-BioNTech and Moderna vaccines is spurring a delay in second dose administration by some nations, especially those with limited supplies of the jabs.A new research study released by the United States Centers for Disease Control and Prevention (CDC) has revealed that the COVID-19 vaccines
Read More
The Food and Drug Administration has approved the Pfizer COVID-19 vaccine, paving way for close to three million highly-vulnerable Americans to receive the vaccine next week.In a letter to Pfizer Inc (NYSE: PFE) on Friday, the FDA revealed it had issued an Emergency Use Authorization (EUA) for the use of
Read More
The Pfizer and BioNTech COVID-19 vaccine is now clinically safe and would be made available for use by next week with priority given to the most vulnerable group.The UK on Wednesday took a very bold step to authorize the Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine
Read More
American pharmaceuticals giant Pfizer Inc (NYSE: PFE) and German biotech firm BioNTech SE (NASDAQ: BNTX) have submitted applications for their coronavirus vaccine in Europe. The two believe they will receive the nod to roll out the vaccine in Europe before the end of 2020. In a press release, Pfizer and
Read More
Pfizer is on track to deliver up to 50 million doses in 2020 and about 1.3 billion doses in 2021.The duo of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) has applied for an Emergency Use Authorization (EUA) with the United States Food and Drug Administration (FDA) for its
Read More
Following the positive news about the Pfizer COVID-19 vaccine efficacy, the stock market has responded with big jumps.The first interim COVID-19 vaccine analysis result from the duo of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) is out and the COVID-19 vaccine candidate shows about 90% efficacy. Per the
Read More
For the Pfizer and BioNTech coronavirus vaccine to be approved by the U.S. FDA, they will have to provide the regulatory body with at least two months of safety data.Shares of Pfizer Inc (NYSE: PFE) jumped approximately 2.19% during Friday’s pre-market to trade around $37.36, they continued their growth as
Read More